Showing 10,201 - 10,220 results of 44,759 for search '(( 5 ((ng decrease) OR (mean decrease)) ) OR ( 50 ((teer decrease) OR (a decrease)) ))', query time: 0.76s Refine Results
  1. 10201

    Mean histopathological severity scores in control, paraquat and MPTP-treated groups of C57BL/6J male mice. by Richard Jay Smeyne (3278886)

    Published 2016
    “…Serial sections through the SNpc were evaluated qualitatively and the group mean severity grades are plotted. Grades 0 to 5 reflect increasing intensity of staining for Iba-1, AmCuGg, GFAP and decreased staining intensity of TH.…”
  2. 10202
  3. 10203

    Supplementary Material for: Association of platelet count and mean platelet volume with fish intake frequency: Implication for the cardioprotective effect of fish intake by figshare admin karger (2628495)

    Published 2025
    “…Introduction: Mean platelet volume (MPV) measures platelet activity, and high values indicate increased atherosclerotic cardiovascular disease (ASCVD) risk. …”
  4. 10204

    CsrA modulates the expression of a thiamine pyrophosphate (TPP) riboswitch element. by Tobias Sahr (3756775)

    Published 2017
    “…<b>B</b>) EMSA with 200nM of biotinylated thi-element (TPP) RNA and purified CsrA: Lane 1: no CsrA, lane 2: 1.0 μM CsrA, lane 3: 2.0 μM CsrA, lane 4: 5.0 μM CsrA, lane 5: 5.0 μM CsrA + 2.0 μM unlabeled RsmZ. …”
  5. 10205

    Depletion of xlPTP4A3 inhibits both migration of NCC and uveal melanoma cells. by Selma Maacha (501715)

    Published 2013
    “…B) Timelapse videomicroscopy of stage 17-derived NCC treated with a pharmacological inhibitor of PTP4A3, a rhodanine derivative (PRL-3 inhibitor I), shows that inhibition of PTP4A3 increases the average of pausing NC cells and strongly decreases the migration velocity of the treated cells (relative to that of vehicle treated cells). …”
  6. 10206
  7. 10207

    De-identified dataset. by Zeshan A. Chisty (18388200)

    Published 2024
    “…</p><p>Results</p><p>The median age of the 37 participants at enrollment was 70.5 years; 30 (81%) had prior SARS-CoV-2 infection, and 76% received Pfizer-BioNTech and 24% Moderna homologous vaccines. …”
  8. 10208

    Simultaneous imaging of cell shape, mitochondrial potential and nuclear modifications at the onset and during the various stages of apoptosis. by Frédérique Nolin (2151472)

    Published 2016
    “…Simultaneous time-lapse confocal imaging of cell shape (DIC), TMRE and H2B-GFP was performed by two-photon excitation every five minutes for 7 hours and 15 minutes after the induction of apoptosis by the addition of 500 ng/mL AMD. …”
  9. 10209
  10. 10210

    ND5 mutant mitochondria have a reduced ability to buffer calcium. by Matthew McKenzie (849898)

    Published 2016
    “…Control (CON) cybrid mitochondria were able to buffer more calcium than both ND5 mutant cybrid mitochondria and ρ<sup>0</sup> cell mitochondria. …”
  11. 10211

    Root phenotype of <i>ibr5</i> alleles compared to wild-type. by Kim L. Johnson (204164)

    Published 2015
    “…L<i>er</i> roots show a 55<b>%</b> decrease in root length when grown on 10 mM IAA compared to un-supplemented medium and <i>tink/ibr5-6</i> plants show a similar root inhibition phenotype (p value ≤ 0.3). …”
  12. 10212

    DN Rab5 (S34N) retards endocytosis of KCa2.3. by Yajuan Gao (309862)

    Published 2013
    “…</b> Expression of S34N Rab5 resulted in a significant decrease of KCa2.3 endocytosis, relative to WT Rab5 (<i>n</i> = 3; *P<0.05). …”
  13. 10213
  14. 10214

    Influence of COS on the activation of NF-κB in retina and RGC-5 cells. by I-Mo Fang (470460)

    Published 2013
    “…(B) COS decreased the amount of activated NF-κB translocated into nucleus in PQ-stimulated RGC-5 in a time-dependent and (C) dose-dependent manner. …”
  15. 10215
  16. 10216
  17. 10217
  18. 10218

    Subgroup analysis. by Bruno Martins Tomazini (6509528)

    Published 2024
    “…</p><p>Results</p><p>From September 25, 2021, to February 3, 2022, 153 patients were randomized. The mean decay rate in SARS-CoV-2 viral load log<sub>10</sub> within 10 days was -3.75 (95% CI, -4.11; -3.19) in the placebo group, -3.83 (95% CI, -4.40; -2.27) in the halofuginone 0.5mg group and -4.13 (95% CI, -4.69; -3.57) in the halofuginone 1mg group, with no statistically significant difference in between placebo vs. halofuginone 0.5mg (mean difference -0.08; 95% CI -0.82 to 0.66, p = 0.96) and between placebo vs. halofuginone 1mg (mean difference -0.38; 95% CI, -1.11; 0.36, p = 0.41). …”
  19. 10219

    Study outcomes. by Bruno Martins Tomazini (6509528)

    Published 2024
    “…</p><p>Results</p><p>From September 25, 2021, to February 3, 2022, 153 patients were randomized. The mean decay rate in SARS-CoV-2 viral load log<sub>10</sub> within 10 days was -3.75 (95% CI, -4.11; -3.19) in the placebo group, -3.83 (95% CI, -4.40; -2.27) in the halofuginone 0.5mg group and -4.13 (95% CI, -4.69; -3.57) in the halofuginone 1mg group, with no statistically significant difference in between placebo vs. halofuginone 0.5mg (mean difference -0.08; 95% CI -0.82 to 0.66, p = 0.96) and between placebo vs. halofuginone 1mg (mean difference -0.38; 95% CI, -1.11; 0.36, p = 0.41). …”
  20. 10220

    Intranasal NIC-hLYS is efficacious in vivo against MERS-CoV. by Ashlee D. Brunaugh (4263472)

    Published 2021
    “…<p>The efficacy of NIC-hLYS particles was assessed in a lethal MERS-CoV infection model (A). Once daily intranasal administration of NIC-hLYS particles suspended in 0.45% sodium chloride resulted in 43% survival in a lethal MERS-CoV infection (B) and produced a statistically significant decrease in lung viral titer at the highest dose tested (C). …”